Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults

Clinical trial NCT02480998 · COMPLETED

Trial details

NCT number: NCT02480998
Sponsor: Il-Yang Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2015-02-01
Primary completion: 2015-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.